1. Search Result
Search Result
Results for "

KB

" in MedChemExpress (MCE) Product Catalog:

1027

Inhibitors & Agonists

9

Screening Libraries

5

Fluorescent Dye

11

Biochemical Assay Reagents

42

Peptides

4

MCE Kits

4

Inhibitory Antibodies

464

Natural
Products

16

Recombinant Proteins

58

Isotope-Labeled Compounds

19

Antibodies

1

Click Chemistry

12

Oligonucleotides

Targets Recommended:
Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-120026

    KB015

    Thyroid Hormone Receptor Neurological Disease
    KB130015 (KB015) is an orally active and potent ThRα and ThRβ (Thyroid Hormone Receptor) inhibitor, with IC50 values of 4.5 and 5.1 μM, respectively. KB130015 has antiarrhythmic properties. KB130015 markedly slows the kinetics of inactivation of Na + channels. KB130015 opens large-conductance Ca 2+-activated K + channels and relaxes vascular smooth muscle .
    KB130015
  • HY-137478A

    CDK Cancer
    KB-0742 dihydrochloride is a potent, selective and orally active CDK9 inhibitor with an IC50 of 6 nM for CDK9/cyclin T1. KB-0742 dihydrochloride is selective for CDK9/cyclin T1 with >50-fold selectivity over other CDK kinases. KB-0742 dihydrochloride has potent anti-tumor activity .
    KB-0742 dihydrochloride
  • HY-137478

    CDK Cancer
    KB-0742 is a potent, selective and orally active CDK9 inhibitor with an IC50 of 6 nM for CDK9/cyclin T1. KB-0742 is selective for CDK9/cyclin T1 with >50-fold selectivity over other CDK kinases. KB-0742 has potent anti-tumor activity .
    KB-0742
  • HY-131385

    Ligands for E3 Ligase Cancer
    KB02-COOH is a fragment of synthesis of ubiquitin E3 ligase ligand KB02. KB02 can be used in the synthesis of PROTAC, such as KB02-JQ1 (HY-129917) and KB02-SLF (HY-129610) .
    KB02-COOH
  • HY-129610

    PROTACs FKBP Cancer
    KB02-SLF is a PROTAC-based nuclear FKBP12 degrader (molecular glue). KB02-SLF promotes nuclear FKBP12 degradation by covalently modifying DCAF16 (E3 ligase) and can improve the durability of protein degradation in biological systems. SLF binds ubiquitin E3 ligase ligand KB02 via a linker to form KB02-SLF .
    KB02-SLF
  • HY-149461

    Others Others
    KB-05 is an electrophilic fragment molecule that can be used in DIA-based quantitative chemical proteomic screening studies.
    KB-05
  • HY-117578

    Others Neurological Disease
    KB 5666 is a benzoxazine derivative with lipid peroxidation inhibitory activity. KB 5666 showed protective effects against post-ischemic neuronal death. KB 5666 effectively protected CA1 neurons when injected 5 minutes before or immediately after ischemia. KB 5666 also showed a dose-dependent protective effect when injected within 1 hour after ischemia. KB 5666 effectively prevented the significant decrease in microtubule-associated protein 2 immunoreactivity within the dendritic field of CA1 pyramidal cells. KB 5666 prevented the decrease in [3H]PDBu binding activity in different layers of the CA1 region after ischemia. The application of KB 5666 showed the ability to improve the cellular and functional consequences of ischemia .
    KB 5666
  • HY-19081

    Bacterial Antibiotic Infection
    KB-5246 is a tetracyclic quinolone and displays antibacterial activities.
    KB-5246
  • HY-117167

    Thyroid Hormone Receptor Cancer
    KB-141 is a potent and selective TRβ agonist. The IC50 values are 23.9 nM and 3.3 nM for binding affinities from displacement of T3 from hTRα1 and hTRβ1, respectively. KB-141 has anti-obesity, anti-diabetic, and lipid-lowering effects?and can be used as an anti-cholesteremic agent in vivo .
    KB-141
  • HY-147196

    Others
    KB03-SLF is a protein degrader that has the activity of targeting specific proteins and can regulate protein levels in cells by inducing protein degradation. This mechanism of KB03-SLF makes it potentially useful in inhibiting related diseases.
    KB03-SLF
  • HY-106239

    KB 944

    Calcium Channel Cardiovascular Disease
    Fostedil (KB 944) is a calcium antagonist that can be used in the research of heart diseases such as angina pectoris .
    Fostedil
  • HY-19120

    Sigma Receptor Inflammation/Immunology
    KB-5492 anhydrous is a potent and selective inhibitor of sigma receptor, inhibits specific [ 3H]1,3-di(2-tolyl)guanidine (DTG) binding to the sigma receptor with an IC50 of 3.15 μM. KB-5492 anhydrous is an anti-ulcer agent .
    KB-5492 anhydrous
  • HY-129917
    KB02-JQ1
    3 Publications Verification

    PROTACs Epigenetic Reader Domain Cancer
    KB02-JQ1 is a highly selective and PROTAC-based BRD4 degrader (molecular glue), but does not degrade BRD2 or BRD3. KB02-JQ1 promotes BRD4 degradation by covalently modifying DCAF16 (E3 ligase) and can improve the durability of protein degradation in biological systems. JQ1 binds ubiquitin E3 ligase ligand KB02 via a linker to form KB02-JQ1 .
    KB02-JQ1
  • HY-142069

    MMP Endocrinology
    KB-R7785 is a novel matrix metalloproteinase (MMP) inhibitor, which improves insulin sensitivity by inhibiting TNF-α production. KB-R7785 can be used for diabetes research. KB-R7785 has a protective efficacy against focal cerebral ischemia .
    KB-R7785
  • HY-47228

    Sigma Receptor Inflammation/Immunology
    KB-5492 free base is a potent and selective inhibitor of sigma receptor, inhibits specific [ 3H]1,3-di(2-tolyl)guanidine (DTG) binding to the sigma receptor with an IC50 of 3.15 μM. KB-5492 free base is an anti-ulcer agent .
    KB-5492 free base
  • HY-101689

    KB 95; NSC 73254

    Others Inflammation/Immunology
    Benzpiperylone (KB 95) is a synthetic drug with potent anti-inflammatory properties.
    Benzpiperylone
  • HY-138947

    Na+/Ca2+ Exchanger Cardiovascular Disease
    KB-R7943 (compound 1) is an inhibitor of sodium-calcium exchanger with an IC50 value of 5.1 μM. KB-R7943 can be used as a tool in heart and renal failure models .
    KB-R7943
  • HY-P99207

    KB 003

    SARS-CoV Cancer
    Lenzilumab (KB 003) is a human monoclonal antibody targeting CSF2/GM-CSF for COVID-19, chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML) studies .
    Lenzilumab
  • HY-15415
    KB-R7943 mesylate
    4 Publications Verification

    Na+/Ca2+ Exchanger Autophagy Cancer
    KB-R7943 mesylate is a widely used inhibitor of the reverse Na +/Ca 2+ exchanger (NCXrev) with IC50 of 5.7±2.1 μM. KB-R7943 mesylate induces cancer cell death via activating the JNK pathway and blocking autophagic flux.
    KB-R7943 mesylate
  • HY-15573

    KB-145943

    Histone Methyltransferase Apoptosis Cancer
    EI1 (KB-145943) is a potent and selective?EZH2?inhibitor with?IC50?of 15 nM and 13 nM for EZH2 (WT) and EZH2 (Y641F), respectively.
    EI1
  • HY-10473

    KB2115

    Thyroid Hormone Receptor Metabolic Disease Endocrinology
    Eprotirome (KB2115) is a liver-selective thyroid hormone receptor (TR) agonist. KB2115 has modestly higher affinity for TRβ than for TRα. Eprotirome reduces low-density lipoprotein (LDL) cholesterol concentrations. Eprotirome can be used for dyslipidemias and obesity research .
    Eprotirome
  • HY-15528

    PKD Cancer
    kb NB 142-70 is a potent PKD inhibitor, with IC50s of 28.3, 58.7 and 53.2 nM for PKD1, PKD2, and PKD3, respectively. kb NB 142-70 also has antitumor activity.
    kb NB 142-70
  • HY-108488

    Src Cancer
    KB SRC 4 is a potent, and highly selective c-Src inhibitor, with a Ki of 44 nM and a Kd of 86 nM, and shows no inhibition on c-Abl up to 125 μM; KB SRC 4 has antitumor activity.
    KB SRC 4
  • HY-16698

    Others Cancer
    kb-NB77-78 is an analogue of CID797718, but shows no PKD inhibitory activity .
    kb-NB77-78
  • HY-P99655

    KB004

    Ephrin Receptor Apoptosis Cancer
    Ifabotuzumab (KB004) is an IgG1κ antibody targeting EphA3 (KD=610 pM). Ifabotuzumab induces tumor cell apoptosis, activates Antibody-dependent cell mediated cytotoxicity (ADCC), and damages tumor vasculature. Ifabotuzumab reduces human idiopathic pulmonary fibrosis (IPF) CCR10 + cells and improves pulmonary fibrosis .
    Ifabotuzumab
  • HY-B0768A

    KB-2796

    Calcium Channel Neurological Disease
    Lomerizine dihydrochloride is an antagonist of L- and T-type voltagegated calcium channels.
    Lomerizine dihydrochloride
  • HY-B0768

    KB-2796 free base

    Calcium Channel Neurological Disease
    Lomerizine is an antagonist of L- and T-type voltagegated calcium channels.
    Lomerizine
  • HY-12170
    Prinomastat
    2 Publications Verification

    AG3340; KB-R9896

    MMP Apoptosis Cancer
    Prinomastat (AG3340) is a broad spectrum, potent, orally active metalloproteinase (MMP) inhibitor with IC50s of 79, 6.3 and 5.0 nM for MMP-1, MMP-3 and MMP-9, respectively. Prinomastat inhibits MMP-2, MMP-3, MMP-13 and MMP-9 with Kis of 0.05 nM, 0.3 nM, 0.03 nM and 0.26 nM, respectively. Prinomastat crosses blood-brain barrier. Antitumor avtivity .
    Prinomastat
  • HY-12170A
    Prinomastat hydrochloride
    2 Publications Verification

    AG3340 hydrochloride; KB-R9896 hydrochloride

    MMP Apoptosis Cancer
    Prinomastat hydrochloride (AG3340 hydrochloride) is a broad spectrum, potent, orally active metalloproteinase (MMP) inhibitor with IC50s of 79, 6.3 and 5.0 nM for MMP-1, MMP-3 and MMP-9, respectively. Prinomastat hydrochloride inhibits MMP-2, MMP-3, MMP-13 and MMP-9 with Kis of 0.05 nM, 0.3 nM, 0.03 nM and 0.26 nM, respectively. Prinomastat hydrochloride can cross blood-brain barrier. Antitumor avtivity .
    Prinomastat hydrochloride
  • HY-RS12262

    Small Interfering RNA (siRNA) Others

    RPS6KB1 Human Pre-designed siRNA Set A contains three designed siRNAs for RPS6KB1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    RPS6KB1 Human Pre-designed siRNA Set A
    RPS6KB1 Human Pre-designed siRNA Set A
  • HY-RS12263

    Small Interfering RNA (siRNA) Others

    Rps6kb1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rps6kb1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Rps6kb1 Mouse Pre-designed siRNA Set A
    Rps6kb1 Mouse Pre-designed siRNA Set A
  • HY-RS12264

    Small Interfering RNA (siRNA) Others

    Rps6kb1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Rps6kb1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Rps6kb1 Rat Pre-designed siRNA Set A
    Rps6kb1 Rat Pre-designed siRNA Set A
  • HY-RS12265

    Small Interfering RNA (siRNA) Others

    RPS6KB2 Human Pre-designed siRNA Set A contains three designed siRNAs for RPS6KB2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    RPS6KB2 Human Pre-designed siRNA Set A
    RPS6KB2 Human Pre-designed siRNA Set A
  • HY-RS12266

    Small Interfering RNA (siRNA) Others

    Rps6kb2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Rps6kb2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Rps6kb2 Mouse Pre-designed siRNA Set A
    Rps6kb2 Mouse Pre-designed siRNA Set A
  • HY-RS12267

    Small Interfering RNA (siRNA) Others

    Rps6kb2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Rps6kb2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Rps6kb2 Rat Pre-designed siRNA Set A
    Rps6kb2 Rat Pre-designed siRNA Set A
  • HY-RS10469

    Small Interfering RNA (siRNA) Others

    PI4KB Human Pre-designed siRNA Set A contains three designed siRNAs for PI4KB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    PI4KB Human Pre-designed siRNA Set A
    PI4KB Human Pre-designed siRNA Set A
  • HY-RS10470

    Small Interfering RNA (siRNA) Others

    Pi4kb Mouse Pre-designed siRNA Set A contains three designed siRNAs for Pi4kb gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Pi4kb Mouse Pre-designed siRNA Set A
    Pi4kb Mouse Pre-designed siRNA Set A
  • HY-RS10471

    Small Interfering RNA (siRNA) Others

    Pi4kb Rat Pre-designed siRNA Set A contains three designed siRNAs for Pi4kb gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Pi4kb Rat Pre-designed siRNA Set A
    Pi4kb Rat Pre-designed siRNA Set A
  • HY-117708

    Others Cancer
    Antitumor agent-144 (16) is an antitumor agent, with IC50 values of 2.6 μM and 8.4 μM in L1210 and KB cells, respectively .
    Antitumor agent-144
  • HY-N3916

    (+)-Galanolactone

    Fungal Infection
    Galanolactone is a natural product that can be isolated from the seeds of Alpinia galanga. Galanolactone shows antifungal activitie. Galanolactone shows cytotoxicity against KB cells with an EC50 of 38.5 µg/ml .
    Galanolactone
  • HY-126598

    Endogenous Metabolite Cancer
    Chaetoglobosin F is a cytochalasan-based alkaloid from Chaetomium globosum. Chaetoglobosin F exhibits cytotoxicity against human nasopharyngeal epidermoid tumor cell KB, with IC50 of 52.0 µM .
    Chaetoglobosin F
  • HY-N7302

    Others Cancer
    Anthracophyllone is an aristolane sesquiterpene that can be isolated from the mushroom Anthracophyllum. Anthracophyllone has cytotoxicity against MCF-7, KB, NCI-H187, Vero cells (IC50: 32.97, 18.02, 15.17, 18.06 μM) .
    Anthracophyllone
  • HY-N12607

    Others Cancer
    Garcilatelic acid (Compound 5) is a compound that can be isolated from Garcinia lateriflora. Garcilatelic acid has antiproliferative activity against tumor cell lines (A549, MDA-MB-231, MCF-7, KB and KB-VIN), with IC50 values of 0.5-1.3 μM .
    Garcilatelic acid
  • HY-129672

    25-Dihydrostichorrenoside E

    Others Cancer
    Thelenotoside B (25-Dihydrostichorrenoside E) shows strong cytotoxicities against five cancer cell lines as HepG2, KB, LNCaP, MCF7 and SK-Mel2 with the IC50 values from 0.95 ± 0.08 to 1.90 ± 0.13 μM. Thelenotoside B is a triterpene tetraglycoside .
    Thelenotoside B
  • HY-N2779

    Others Cancer
    8-Lavandulylkaempferol is a flavonoid that can be isolated from Sophora flaWescens. 8-Lavandulylkaempferol exhibits cytotoxic activity against the KB epidermoid carcinoma cell line with an IC50 of 15.1 μg/mL .
    8-Lavandulylkaempferol
  • HY-N8462

    Scutebatin C

    Others Cancer
    6-O-Nicotinoylscutebarbatine G is an alkaloid that can be isolated from Scutellaria barbata.6-O-Nicotinoylscutebarbatine has cytotoxic activities against HONE-1, KB and HT29 cells with IC50s of 3.1, 2.1 and 5.7 μM, respectively .
    6-O-Nicotinoylscutebarbatine G
  • HY-N2863

    Others Cancer
    Goniothalenol is a styryl lactone that can be isolated from Goniothalamus griffithii. Goniothalenol exhibits cytatoxic activity against A2780, HCT-8, KB and MCF-7 cell lines .
    Goniothalenol
  • HY-76569

    PNU-200577; 5-Hydroxymethyl Tolterodine

    mAChR Neurological Disease
    Desfesoterodine (PNU-200577) is a potent and selective muscarinic receptor (mAChR) antagonist with a KB and a pA2 of 0.84 nM and 9.14, respectively . Desfesoterodine is a major pharmacologically active metabolite of Tolterodine (PNU-200583; HY-A0024) and Fesoterodine (HY-70053) . Desfesoterodine improves cerebral infarction induced detrusor overactivity in rats .
    Desfesoterodine
  • HY-76569S1

    PNU-200577-d14; 5-Hydroxymethyl Tolterodine-d14

    mAChR Isotope-Labeled Compounds Neurological Disease
    (R)-Hydroxytolterodine-d14 is deuterated labeled Desfesoterodine (HY-76569). Desfesoterodine (PNU-200577) is a potent and selective muscarinic receptor (mAChR) antagonist with a KB and a pA2 of 0.84 nM and 9.14, respectively . Desfesoterodine is a major pharmacologically active metabolite of Tolterodine (PNU-200583; HY-A0024) and Fesoterodine (HY-70053) . Desfesoterodine improves cerebral infarction induced detrusor overactivity in rats .
    (R)-Hydroxytolterodine-d14
  • HY-76569R

    mAChR Neurological Disease
    Desfesoterodine (Standard) is the analytical standard of Desfesoterodine. This product is intended for research and analytical applications. Desfesoterodine (PNU-200577) is a potent and selective muscarinic receptor (mAChR) antagonist with a KB and a pA2 of 0.84 nM and 9.14, respectively . Desfesoterodine is a major pharmacologically active metabolite of Tolterodine (PNU-200583; HY-A0024) and Fesoterodine (HY-70053) . Desfesoterodine improves cerebral infarction induced detrusor overactivity in rats .
    Desfesoterodine (Standard)

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: